Concepedia

R. D. Hofheinz

RD

Statistics

Publications

4

Citations

173

H-Index

4

Active since

2005

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

Krankenhaus Barmherzige Brüder

University Hospital Frankfurt

University Medical Centre Mannheim

R. D. Hofheinz is an author at Heidelberg University specializing in oncology, medicine, and colorectal cancer neoadjuvant therapy.

Publications per year

2005–2025

4

Publications

4

Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

G. Hartung, R. D. Hofheinz, Y. Dencausse et al. · Oncology Research and Treatment · 2005 · 64 citations

, , +17

Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?

Karoline Horisberger, R. D. Hofheinz, P. Palma et al. · International Journal of Colorectal Disease · 2007 · 41 citations

, , +17

Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials

Hannah L. Williams, Emmanouil Fokas, Markus Diefenhardt et al. · Annals of Oncology · 2025 · 37 citations · Full text

, , +15

1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK

S-E. Al-Batran, Sylvie Lorenzen, Nils Homann et al. · Annals of Oncology · 2021 · 31 citations

, , +13

1–4 of 4